Semaglutide: Selective GLP-1 receptor agonist that suppresses appetite, delays gastric emptying, and enhances glucose-dependent insulin secretion
Prioritizing protein-rich meals and snacks helps ensure the body has what it needs for muscle retention, even when overall appetite is low
Skipping doses or starting higher increases the risk of severe nausea, vomiting, and other gastrointestinal side effects that could derail the entire switch
When taking blood pressure, sit upright with feet on the ground
Semaglutide, a GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management, does not have an established lethal dose in humans
Beneficios Control estable de la glucosa en sangre Favorece la prdida de peso Reduce el riesgo cardiovascular Aplicacin semanal cmoda y segura